[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sino Biopharmaceutical is acquiring LaNova Medicines for up to $XXX million, leading to positive sentiment and price increases. The acquisition is expanding its oncology capabilities and global reach.
Sino Biopharmaceutical Limited is a pharmaceutical company.
Price 24-Hour Chart Data
The price is rising, hitting a daily high of $XXXX and a 1-year high of $6.90, likely due to increased social media engagement, positive analyst comments, the COVID-19 wave in Asia, and the acquisition of LaNova Medicines.
1-Year High: $XXXX on 2025-07-18
1-Year Low: $XXXX on 2024-07-30
AltRank 24-Hour Chart Data
Sino Biopharmaceutical Limited is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-03
1-Year Low: XXX on 2025-02-27
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-07-16
1-Year Low: XX on 2025-07-18
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX +64,472%
1-Year High: XXXXXX on 2025-07-15
1-Year Low: X on 2025-02-24
Social Network | X | News | YouTube |
---|---|---|---|
Engagements | XXX | XX | X |
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +39%
1 Month: XX +383%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-02-24
Social Network | X | News | YouTube |
---|---|---|---|
Mentions | XX | X | X |
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Sino Biopharmaceutical Limited in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: X
1 Week: XX +46%
1 Month: XX +267%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-02-24
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1-Year High: XXX% on 2025-07-15
1-Year Low: XX% on 2025-07-07
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XX | XX% | XXX | XX% | X | X% |
News | X | X% | XX | XX% | X | X% |
YouTube | X | X% | X | X% | X | X% |
Total | XX | XX% | XXX | XX% | X | X% |
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-04
1-Year Low: $XXXXXXXXXXXXXX on 2025-02-11
Top assets mentioned In the posts about Sino Biopharmaceutical Limited in the last XX hours
Top topics mentioned In the posts about Sino Biopharmaceutical Limited in the last XX hours
china, acquisition, $951m, han, $4507t, stocks, pfe, $bntx, $588m, investment, $mrk, stocks healthcare, web3, iran, hodl, #crypto, #bitcoin, capabilities, $500m, networks, Sentiment, $950m, preorder, $2015hk, $9688hk, $2359hk, $2269hk, $1801hk, ist, von, spa
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Han Kun Law Offices and @zhonglunlawfirm have taken lead legal roles in a China acquisition where Sino Biopharmaceutical acquires LaNova Medicines for up to USD950 million. See more in @CBLJ_insights. #cblj #china #capitalmarkets #lawfirms #lawyers #law"
@CBLJ_insights on X 2025-07-23 08:00:00 UTC XXX followers, X engagements
"Han Kun Law Offices and Zhong Lun Law Firm have taken lead legal roles in a China acquisition where drug giant Sino Biopharmaceutical acquires cancer treatment manufacturer LaNova Medicines for up to USD950 million. Read more 👇 #cblj #china #investment"
@CBLJ_insights on X 2025-07-21 06:00:34 UTC XXX followers, XX engagements
"HSI -XXX% Beijing targets irrational competition in EV market $175.HK +4% merge with Zeekr $2015.HK +10% starts new pre-order of SUV model $1177.HK +5% will buy remaining XX% stake in LaNova medicine for $950m; signalling first China to China M&A for the pharma sector"
@vinhtk5 on X 2025-07-17 09:48:38 UTC X followers, XX engagements